Clinical Trial Update: Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

This Phase 2 dose-finding safety study of a plasmid DNA therapeutic vaccine for cervical intraepithelial neoplasia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Plasmid DNA Therapeutic Vaccine (plasmid DNA therapeutic vaccine)

Snippet

Sponsor: Genexine, Inc. | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED